Want to join the conversation?
$AKRX said it is focused on replenishing its ANDA pipeline and anticipates filing approx. 20 new filings in 2016. The company is in the process of expanding is R&D footprint by expanding its current facilities and adding a new R&D facility in the New Jersey pharma corridor.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.